N1-Ethylpseudouridine Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

A modified NTP for incorporation into messenger RNAs (mRNA) using T7 RNA Polymerase. Incorporation of N1-ethylpseudouridine can reduce the immunogenicity of the resulting mRNA.

N1-Ethylpseudouridine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N1-Ethylpseudouridine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shenzhen Nexconn Pharmatechs Ltd	+86-755-89396905 +86-15013857715	admin@nexconn.com	China	10310	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
SHANGHAI T&W PHARMACEUTICAL CO., LTD.	+86-021-61551413 +8618813727289	contact@trustwe.com	China	5738	58
NewCan Biotech Limited	+86-0571-86912261 +8613735419629	sales@newcanbio.com	China	9980	58
TargetMol Chemicals Inc.		support@targetmol.com	United States	38469	58
PANNACEAN(HENAN)MEDICINE SCIENCE TECHNOLOGIES LTD	0371-55159968 18137130222	haifeng.zhang@pannacean.com	China	527	58
Zhengzhou Chemprize Biotech Co., Ltd.	+86-86-0371-56768238 +8615981919713	sales@chemprize.com	China	297	58
T&W GROUP	021-61551611 13296011611	contact@trustwe.com	China	9895	58
Zhengzhou GranLen pharmaceutical Technology Co., Ltd.	0371-85513397	info@granlen.com	China	497	55
Zhengzhou Granlen Sciences, ltd.	0371-85513397 +86-18610099868;	info@granlen.com	China	1842	58

---

• N1-Ethylpseudouridine
• 1-ethyl-pseudouridine
• 2,4(1H,3H)-Pyrimidinedione, 1-ethyl-5-β-D-ribofuranosyl-
• 1613529-72-8
• Pharmaceutical